Why the study?
Is ongoing dysglycaemia associated with persistent infarct core iron in STEMI patients treated with primary PCI?
Is ongoing dysglycaemia associated with persistent infarct core iron in STEMI patients treated with primary PCI?
Answers are grounded in this paper and cite their sources.
Ongoing dysglycaemia is associated with persistent infarct core iron in STEMI patients after primary PCI, highlighting a potential therapeutic target for improving myocardial healing.
In STEMI patients treated with primary PCI, ongoing dysglycaemia defined by HbA1c is independently associated with persistent infarct core iron and a lower likelihood of iron resolution. These findings suggest a potential association between ongoing dysglycaemia and persistent infarct core iron, which warrants further investigation for therapeutic implications.
No takes yet. Share an insight, caveat, or question.
Lechner et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: